These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 18444100)

  • 21. MMPI and Rorschach indices of schizophrenic and depressive diagnoses among adolescent inpatients.
    Archer RP; Gordon RA
    J Pers Assess; 1988; 52(2):276-87. PubMed ID: 3404390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification accuracy of MMPI-2 validity scales in the detection of pain-related malingering: a known-groups study.
    Bianchini KJ; Etherton JL; Greve KW; Heinly MT; Meyers JE
    Assessment; 2008 Dec; 15(4):435-49. PubMed ID: 18539782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validity rates of the Personality Assessment Inventory and the Minnesota Multiphasic Personality Inventory-2 in a VA Medical Center Setting.
    Braxton LE; Calhoun PS; Williams JE; Boggs CD
    J Pers Assess; 2007 Feb; 88(1):5-15. PubMed ID: 17266409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overreport on the MCMI-III: concurrent validation with the MMPI-2 using a psychiatric inpatient sample.
    Morgan CD; Schoenberg MR; Dorr D; Burke MJ
    J Pers Assess; 2002 Apr; 78(2):288-300. PubMed ID: 12067194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of response frequency on the Rorschach constellation indices and on their validity with diagnostic and MMPI-2 criteria.
    Meyer GJ
    J Pers Assess; 1993 Feb; 60(1):153-80. PubMed ID: 8433265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of the PAI and the MMPI-2 for discriminating PTSD, depression, and social phobia in trauma-exposed college students.
    McDevitt-Murphy ME; Weathers FW; Flood AM; Eakin DE; Benson TA
    Assessment; 2007 Jun; 14(2):181-95. PubMed ID: 17504890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing depression with the MMPI and MMPI-2.
    Gross K; Keyes MD; Greene RL
    J Pers Assess; 2000 Dec; 75(3):464-77. PubMed ID: 11117157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MMPI-A and Rorschach indices related to depression and conduct disorder: an evaluation of the incremental validity hypothesis.
    Archer RP; Krishnamurthy R
    J Pers Assess; 1997 Dec; 69(3):517-33. PubMed ID: 9501482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnosis using the MMPI-2: Goldberg's index revisited.
    Egger JI; Delsing PA; De Mey HR
    Eur Psychiatry; 2003 Dec; 18(8):409-11. PubMed ID: 14680717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An examination of three sets of MMPI-2 personality disorder scales.
    Jones A
    J Pers Disord; 2005 Aug; 19(4):370-85. PubMed ID: 16178680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of exposure to Internet-based information about the Rorschach and the MMPI-2 on psychiatric outpatients' ability to simulate mentally healthy test performance.
    Hartmann E; Hartmann T
    J Pers Assess; 2014; 96(4):432-44. PubMed ID: 24528223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of PIC and MMPI scales in adolescent psychosis: a caution.
    Davies A; Lachar D; Gdowski C
    Adolescence; 1987; 22(87):571-8. PubMed ID: 3434381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The validity and utility of the positive presentation management and negative presentation management scales for the Revised NEO Personality Inventory.
    Sellbom M; Bagby RM
    Assessment; 2008 Jun; 15(2):165-76. PubMed ID: 18463407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Internal structure of the MMPI-2 Addiction Potential Scale in alcoholic and psychiatric inpatients.
    Sawrie SM; Kabat MH; Dietz CB; Greene RL; Arredondo R; Mann AW
    J Pers Assess; 1996 Feb; 66(1):177-93. PubMed ID: 8576831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the rorschach and the MMPI-2 in a Swedish population: a replication study of the effects of first-factor related test-interaction styles.
    Lindgren T; Carlsson AM
    J Pers Assess; 2002 Oct; 79(2):357-70. PubMed ID: 12425396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weighing evidence for the Rorschach's validity: a response to Wood et al. (1999).
    Ganellen RJ
    J Pers Assess; 2001 Aug; 77(1):1-15. PubMed ID: 11562095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Rorschach Comprehensive System Egocentricity Index in psychiatric inpatients.
    Barley WD; Dorr D; Reid V
    J Pers Assess; 1985 Apr; 49(2):137-40. PubMed ID: 3998983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can sex offenders who minimize on the MMPI conceal psychopathology on the Rorschach?
    Grossman LS; Wasyliw OE; Benn AF; Gyoerkoe KL
    J Pers Assess; 2002 Jun; 78(3):484-501. PubMed ID: 12146816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No agreement between the Rorschach and self-assessed personality traits derived from the Comprehensive System.
    Lindgren T; Carlsson AM; Lundbäck E
    Scand J Psychol; 2007 Oct; 48(5):399-408. PubMed ID: 17877555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMPI-A validity scale uses and limitations in detecting varying levels of random responding.
    Archer RP; Handel RW; Lynch KD; Elkins DE
    J Pers Assess; 2002 Jun; 78(3):417-31. PubMed ID: 12146812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.